James E. Dentzer - Jan 27, 2022 Form 4 Insider Report for CURIS INC (CRIS)

Role: President & CEO, Director
Signature: William Steinkrauss, attorney-in-fact
Stock symbol: CRIS
Transactions as of: Jan 27, 2022
Transactions value $: -$17,150
Form type: 4
Date filed: 1/31/2022, 04:14 PM
Next filing: Oct 3, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CRIS	Common Stock	Sale	-$7.65K	-2.41K	-3.42%	$3.18	68K	Jan 27, 2022	Direct	F1
transaction	CRIS	Common Stock	Sale	-$9.5K	-3.09K	-4.55%	$3.07	64.9K	Jan 31, 2022	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CRIS	Employee stock option (right to buy)	Award	$0	+825K		$0.00	825K	Jan 29, 2022	Common stock	825K	$3.09	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares were sold pursuant to a "sell to cover" arrangement to satisfy minimum statutory tax withholding obligations related to a vesting of a service-based restricted stock award granted on January 22, 2018.
F2	This transaction was effected pursuant to Rule 10b5-1 trading plans to cover tax obligations.
F3	The option grant described in this Form 4 filing vests as to 25% of the original shares on January 29, 2023 and as to an additional 6.25% of the original shares each successive quarter and until January 29, 2026.